Levemir News and Research

RSS
How a drug company under pressure for high prices ratchets up political activity

How a drug company under pressure for high prices ratchets up political activity

T1DM therapeutics market expected to reach $7.1 billion by 2021

T1DM therapeutics market expected to reach $7.1 billion by 2021

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Novo Nordisk announces $73M expansion of Clayton insulin delivery systems manufacturing facility

Novo Nordisk announces $73M expansion of Clayton insulin delivery systems manufacturing facility

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

Additional benefits of LAIAs over long-acting human insulin not been proven

Additional benefits of LAIAs over long-acting human insulin not been proven

Report on the type 2 diabetes drug market in Brazil

Report on the type 2 diabetes drug market in Brazil

Novo Nordisk's Levemir not associated with increase in the incidence of cancer

Novo Nordisk's Levemir not associated with increase in the incidence of cancer

Decision Resources forecasts biosimilar insulins and insulin analogues to erode $6.1 billion in brand sales

Decision Resources forecasts biosimilar insulins and insulin analogues to erode $6.1 billion in brand sales

FDA releases latest listing of consumer health information updates

FDA releases latest listing of consumer health information updates

Saskatchewan government makes insulin detemir more accessible to residents

Saskatchewan government makes insulin detemir more accessible to residents

Possible link between insulin glargine and cancer prompts urgent call for more research

Possible link between insulin glargine and cancer prompts urgent call for more research

FDA issues health advisory on Levemir insulin

FDA issues health advisory on Levemir insulin

Standard long-acting insulin as good as newer medications

Standard long-acting insulin as good as newer medications